About Antonina Simakova
Antonina Simakova is an executive officer at Myris Therapeutics.
Antonina Simakova first appears on SEC filings in 2022.
Experience
This experience comes from Antonina Simakova's profile and from SEC filings. For roles taken from filings, the years are when the filings name Antonina Simakova in the role, so the role may have started earlier or lasted longer.
Myris Therapeutics, Inc. Current
Chief Technology Officer
2018 – Present · Sharpsburg, PA
Develops antibody-linked medicines for people with cancer.
BL
BioHybrid Solutions LLC
Co-Founder and Director of R&D
2016 – 2018
CU
Carnegie Mellon University
Postdoctoral Research Associate
2010 – 2017
BM
Bayer MaterialScience
Bayer Fellow
2013
IS
Ivanovsky Institute of Virology of Russian Academy of Medical Sciences
Research Assistant
2008 – 2010
UR
University of Rostock
Summer Internship
2009
UG
University of Glasgow
Summer Internship
2007
MC
Max Plank Institure for Bioinorganic Chemistry
Summer Internship
2006
Key Colleagues at Startups
The people Antonina Simakova works with at each company, as listed on that company's latest Form D.
Myris Therapeutics, Inc. · Form D, Oct 14, 2026
Laura Benjamin
CEO, Board Director
RW
Rebecca Wolfe
Executive officer
Alan Russell
Promoter
David Colaizzi
Board Chairman
BF
Barbara Fox
Board Director
Krzysztof Matyjaszewski
Co-Founder and Board Director
Mark Murcko
Board Director